Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
NorthShore University HealthSystem Research Institute More
Product development for cancer, inflammation, and neurodegenerative disease More
SRI Chemical & Health Business Services is the world's leading provider of global chemical and healthcare market research information and advisory services. More
Medinnova bridges medical research and industry. More
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) designs, optimizes and develops novel drugs that block key enzymes essential for viral, cardiovascular and oncologic disease processes. More
Computer-based biological modeling for drug discovery & development More
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Angina
- Angina pectoris
- Angina, chronic stable
- Angina, unstable
- Arrhythmia
- Atrial fibrillation
- Cardiac arrythmia
- Cardiomyopathy
- Congestive heart failure
- Coronary artery disease
- Coronary heart disease
- Heart failure
- Ischaemic heart disease
- Myocardial infarction
- Geographic location
- Canada
- USA
© Copyright 1995-2009 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us